Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-26 4:04 pm Purchase |
2022-09-20 | 13D | Milestone Pharmaceuticals Inc. MIST |
Novo Holdings A/S | 2,097,713 7.000% |
16,828 (+0.81%) |
Filing History |
| 2022-09-19 9:14 pm Purchase |
2022-09-09 | 13G | Milestone Pharmaceuticals Inc. MIST |
Venrock Healthcare Capital Partners III L.P. | 2,072,009 6.900% |
2,072,009 (New Position) |
Filing History |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,238,861 7.500% |
-238,333 (-9.62%) |
Filing History |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,750,043 5.900% |
-86,502 (-4.71%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RA Capital Management, L.P. | 2,246,503 7.500% |
-81,211 (-3.49%) |
Filing History |
| 2022-02-14 08:03 am Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RTW Investments, LP | 4,315,102 14.400% |
-99 (-0.00%) |
Filing History |
| 2022-02-11 4:32 pm Purchase |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
ORBIMED CAPITAL LLC | 2,583,821 8.700% |
90,712 (+3.64%) |
Filing History |
| 2021-02-16 4:57 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,477,194 8.300% |
700,000 (+39.39%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RA Capital Management, L.P. | 2,327,714 7.800% |
2,327,714 (New Position) |
Filing History |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
PRICE T ROWE ASSOCIATES INC | 374,957 1.200% |
-911,550 (-70.85%) |
Filing History |
| 2021-02-16 06:10 am Sale |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Forbion Capital Fund III Cooperatief U.A. | 0 0.000% |
-1,303,902 (Position Closed) |
Filing History |
| 2021-02-12 5:03 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
ORBIMED CAPITAL LLC | 2,493,109 8.360% |
2,493,109 (New Position) |
Filing History |
| 2021-02-12 09:28 am Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RTW Investments, LP | 4,315,201 14.460% |
356,937 (+9.02%) |
Filing History |
| 2021-02-11 7:10 pm Sale |
2021-02-11 | 13G | Milestone Pharmaceuticals Inc. MIST |
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 1,387,393 4.700% |
-1,332,917 (-49.00%) |
Filing History |
| 2021-01-20 6:33 pm Sale |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Domain Partners VIII L.P. | 860,724 2.900% |
-1,012,381 (-54.05%) |
Filing History |
| 2021-01-11 5:25 pm Purchase |
2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,836,545 6.200% |
1,836,545 (New Position) |
Filing History |
| 2020-08-03 4:31 pm Purchase |
2020-07-23 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 1,777,194 7.200% |
1,777,194 (New Position) |
Filing History |